Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

NCT01530711 is registered in ClinicalTrials.gov with Pere Gines as lead sponsor.

NCT NCT01530711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01530711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
Lead sponsor
Pere Gines
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2012
Completion date
December 31, 2016
Enrollment
40 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatorenal syndrome type i